Polymatech Electronics Unlisted Shares
Polymatech Electronics Ltd — To Invest ₹550 Crore in Medical Device Manufacturing Unit in Tamil Nadu
Medical Buyer
1 min read
Expert Analysis:
Polymatech Electronics Limited has announced an investment of ₹550 crore to set up a new medical device manufacturing facility at the SIPCOT Medical Devices Park in Oragadam, Tamil Nadu, after executing a 99-year lease for 4.45 acres of land adjacent to its existing unit.
The expansion comes amid strong demand for its advanced manufacturing capabilities, with the current facility reportedly operating at full capacity, prompting capacity augmentation to support scaling of high-precision medical device production.
The upcoming plant will manufacture a range of advanced medical devices, leveraging the company’s semiconductor expertise, and is expected to generate employment for around 100 engineers, contributing to India’s growing MedTech manufacturing ecosystem.
Additionally, the company is pursuing further expansion with land allotment in Chhattisgarh for a proposed Special Economic Zone (SEZ), indicating a broader multi-location growth strategy in electronics and healthcare manufacturing.
Polymatech’s ₹550 crore investment underscores its strategic diversification into high-value medical device manufacturing, supported by strong existing demand and infrastructure expansion, positioning the company within India’s rapidly evolving MedTech and semiconductor-linked ecosystem.
Precize Daily Pulse
The latest news in the world of Unlisted Shares, summarised by our experts.
Company
Our Office
Office No. 1219, The Summit Business Park, Andheri Kurla Road, Andheri East, Mumbai, Maharashtra - 400093
Find us on Googlesupport@precize.in
+91 7738336457
All trademarks and logos or registered trademarks and logos found on this Site or mentioned herein belong to their respective owners and are solely used for informational and educational purposes.
The material presented in this advertisement is for informational purposes only and should not be construed as investment advice or investment availability. It is not a recommendation of, or an offer to sell or solicitation of an offer to buy, any particular unlisted share, security, strategy, or investment product. Investing in the private market and securities involves risks, including the potential loss of money, and past performance does not guarantee future results. Market trends, data interpretations, graph projections are provided for informational and illustrative purposes and may not reflect actual future performance. Nothing on this website should be construed as personalized investment advice or should not be treated as legal, financial, or any other form of advice. Precize is not liable for financial or any other form of loss incurred by the user or any affiliated party based on information provided herein.
Precize is neither a stock exchange nor does it intend to get recognized as a stock exchange under the Securities Contracts Regulation Act, 1956. Precize is not authorized by the capital markets regulator to solicit investments. The securities traded on these platforms are not traded on any regulated exchange.
The website will be updated regularly.
Copyright © 2026 - Precize - All Rights Reserved